newsfilter
← Latest News
GlobeNewswire·

MacroGenics to Participate in Upcoming Investor Conference

ROCKVILLE, MD, May 01, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics